Patents Assigned to Alessa Therapeutics, Inc.
  • Drug implants containing enzalutamide and methods of use thereof
    Patent number: 11666528
    Abstract: Provided herein are drug implants comprising enzalutamide for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and enzalutamide disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may be used for the treatment of a proliferative disease of the prostate.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: June 6, 2023
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Keith Hall, Pamela Munster, John Maroney, Scott Thomas
  • Implantable drug delivery devices for localized drug delivery
    Patent number: 11344526
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 31, 2022
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Implantable drug delivery devices for localized drug delivery
    Patent number: 11338119
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 24, 2022
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas
  • Implantable drug delivery devices for localized drug delivery
    Patent number: 11173291
    Abstract: Provided herein are drug implants comprising a therapeutically active agent for the treatment of disease in a subject. In some cases, the drug implant may comprise a polymer matrix and a therapeutically active agent disposed therein. Additionally provided are methods for manufacturing the drug implants and methods of treating diseases with the implants. In some cases, the drug implant may comprise bicalutamide, e.g., for use in the treatment of prostate cancer.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: November 16, 2021
    Assignees: The Regents of the University of California, Alessa Therapeutics, Inc.
    Inventors: Maithili Rairkar, Pujan Desai, Carlos Schuler, Maxime Daud, Maxime D. Rappaport, Pamela Munster, John Maroney, Margaret McLaughlin, Tobias H. Casab, Keith Hall, Scott Thomas